(Q35751437)

10 August 2017

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada (English)

1 reference

10 August 2017

0 references

6

S M Cadarette

1 reference

10 August 2017

3

D H Solomon

1 reference

10 August 2017

A M Burden

1

1 reference

10 August 2017

J M Paterson

series ordinal

2

1 reference

10 August 2017

M Mamdani

series ordinal

4

1 reference

10 August 2017

D N Juurlink

series ordinal

5

1 reference

10 August 2017

language of work or name

English

0 references

publication date

21 May 2011

1 reference

Osteoporosis International

10 August 2017

1 reference

10 August 2017

23

1 reference

10 August 2017

3

1 reference

10 August 2017

1075-1082

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-011-1645-7

10 August 2017

0 references

cites work

Osteoporosis quality indicators using healthcare utilization data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Measuring and improving adherence to osteoporosis pharmacotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Impact of osteoporosis treatment adherence on fracture rates in North America and Europe.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

How complete are drug history profiles that are based on public drug benefit claims?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Patient adherence to osteoporosis medications: problems, consequences and management strategies.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3277689

Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong?

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1645-7

Persistence with weekly alendronate therapy among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1645-7

Compliance with osteoporosis medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1645-7

Fracture risk remains reduced one year after discontinuation of risedronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1645-7

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1645-7

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-011-1645-7

Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21604008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21604008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Persistence with bisphosphonate therapy in older people

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21604008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00198-011-1645-7

1 reference

10 August 2017

1 reference

10 August 2017

1 reference